Neurol. praxi. 2023;24(6):458-463 | DOI: 10.36290/neu.2023.055

Epidemiology and genetics of multiple sclerosis

MUDr. Mgr. Matouš Rous
Lékařská fakulta Univerzity Palackého v Olomouci
Neurologická klinika Fakultní nemocnice Olomouc

Multiple sclerosis (MS) is an autoimmune disease in which multiple factors contribute to its development. Currently, more and more studies are devoted to the role of genetics in the development of MS. Studies that mapped large sets of MS patients and controls identified 236 independent genetic variants associated with an increased risk of developing MS. None of these variants are found exclusively in MS patients. MS is primarily mediated by mild changes in gene regulation that result in changes in the functions of peripheral and tissue-bound cells of the immune system. Each genetic risk factor alone represents a small risk, the combination of which creates an individual genetic risk of developing MS. This polygenicity therefore determines the risk of developing MS in every individual. How environmental factors contribute remains a question. The study of genetic background together with epidemiologic studies using Mendelian randomization offer possibilities to demonstrate the causality of these effects. Current research focuses on expanding the cohorts, their diversity, studying them in more detail and translating the associations to understanding the pathophysiology of MS.

Keywords: multiple sclerosis, genetics, epidemiology, singe­‑nucleotide polymorphism, polygenicity.

Received: July 27, 2023; Revised: July 27, 2023; Accepted: August 18, 2023; Prepublished online: August 18, 2023; Published: December 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rous M. Epidemiology and genetics of multiple sclerosis. Neurol. praxi. 2023;24(6):458-463. doi: 10.36290/neu.2023.055.
Download citation

References

  1. Badam TVS, de Weerd HA, Martínez­‑Enguita D, et al. A validated generally applicable approach using the systematic assessment of disease modules by GWAS reveals a multi­‑omic module strongly associated with risk factors in multiple sclerosis. BMC Genomics. 2021;22(1):631. doi: 10.1186/s12864-021-07935-1. PMID: 34461822; PMCID: PMC8404328. Go to original source... Go to PubMed...
  2. Beecham AH, Amezcua L, Chinea A, et al. The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States. Mult Scler. 2020;26(11):1329-1339. doi: 10.1177/1352458519863764. Epub 2019 Aug 1. PMID: 31368393; PMCID: PMC6994382 Go to original source... Go to PubMed...
  3. Bouillon R, Manousaki D, Rosen C, et al. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. 2022;18(2):96-110. doi: 10.1038/s41574-021-00593-z. Epub 2021 Nov 23. PMID: 34815552; PMCID: PMC8609267. Go to original source... Go to PubMed...
  4. Chun S, Casparino A, Patsopoulos NA, et al. Limited statistical evidence for shared genetic effects of eQTLs and autoimmune­‑disease­‑associated loci in three major immune­‑cell types. Nat Genet. 2017;49(4):600-605. doi: 10.1038/ng.3795. Epub 2017 Feb 20. PMID: 28218759; PMCID: PMC5374036. Go to original source... Go to PubMed...
  5. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502-17. doi: 10.1016/S0140-6736(08)61620-7. PMID: 18970977. Go to original source... Go to PubMed...
  6. Gasperi C, Andlauer TFM, Keating A, et al. Genetic determinants of the humoral immune response in MS. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e827. doi: 10.1212/NXI.0000000000000827. PMID: 32675288; PMCID: PMC7371373. Go to original source... Go to PubMed...
  7. Goris A, Vandebergh M, McCauley JL, et al. Genetics of multiple sclerosis: lessons from polygenicity. Lancet Neurol. 2022;21(9):830-842. doi: 10.1016/S1474-4422(22)00255-1. PMID: 35963264. Go to original source... Go to PubMed...
  8. Gourraud PA, McElroy JP, Caillier SJ, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol. 2011;69(1):65-74. doi: 10.1002/ana.22323. PMID: 21280076; PMCID: PMC3511846. Go to original source... Go to PubMed...
  9. Harroud A, Mitchell RE, Richardson TG, et al. Childhood obesity and multiple sclerosis: A Mendelian randomization study. Mult Scler. 2021;27(14):2150-2158. doi: 10.1177/13524585211001781. Epub 2021 Mar 22. PMID: 33749377. Go to original source... Go to PubMed...
  10. Jacobs BM, Noyce AJ, Giovannoni G, Dobson R. BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study. Neurol Neuroimmunol Neuroinflamm. 2020;7(2):e662. doi: 10.1212/NXI.0000000000000662. PMID: 31937597; PMCID: PMC6975169. Go to original source... Go to PubMed...
  11. Jiang X, Zhu Z, Manouchehrinia A, et al. Alcohol Consumption and Risk of Common Autoimmune Inflammatory Diseases­‑Evidence From a Large­‑Scale Genetic Analysis Totaling 1 Million Individuals. Front Genet. 2021;12:687745. doi: 10.3389/fgene.2021.687745. PMID: 34239545; PMCID: PMC8258244. Go to original source... Go to PubMed...
  12. Lincoln MR, Axisa NC, Gasperi P, et al. Joint analysis reveals shared autoimmune disease associations and identifies common mechanisms. medRxiv (Cold Spring Harbor Laboratory); 2021. https://doi.org/10.1101/2021. 05. 13.21257044. Go to original source...
  13. Madireddy L, Patsopoulos NA, Cotsapas C, et al. International Multiple Sclerosis Genetics Consortium. A systems biology approach uncovers cell­‑specific gene regulatory effects of genetic associations in multiple sclerosis. Nat Commun. 2019;10(1):2236. doi: 10.1038/s41467-019-09773-y. Erratum in: Nat Commun. 2019;10(1):2956. PMID: 31110181; PMCID: PMC6527683. Go to original source... Go to PubMed...
  14. Mitchell RE, Bates K, Wootton RE, et al. Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study. PLoS Biol. 020;18(11):e3000973. doi:10.1371/journal.pbio.3000973. PMID: 33253141; PMCID: PMC7728259. Go to original source... Go to PubMed...
  15. Mitrovic M, Patsopoulos NA, Beecham A, et al. Low­‑Frequency and Rare­‑Coding Variation Contributes to Multiple Sclerosis Risk. Cell. 2018;175(6):1679-1687.e7. doi: 10.1016/j.cell.2018. 09. 049. Epub 2018 Oct 18. Erratum in: Cell. 2019 Jun 27;178(1):262. PMID: 30343897; PMCID: PMC6269166. Go to original source...
  16. Moutsianas L, Jostins L, Beecham AH, et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet. 2015;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7. PMID: 26343388; PMCID: PMC4874245. Go to original source... Go to PubMed...
  17. Nelson MR, Tipney H, Painter JL, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856-60. doi: 10.1038/ng.3314. Epub 2015 Jun 29. PMID: 26121088. Go to original source... Go to PubMed...
  18. Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25-36. doi: 10.1038/nrneurol.2016.187. Epub 2016 Dec 9. PMID: 27934854. Go to original source... Go to PubMed...
  19. Patsopoulos NA, Baranzini SE, et al. International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188. doi: 10.1126/science.aav7188. PMID: 31604244; PMCID: PMC7241648. Go to original source... Go to PubMed...
  20. Patsopoulos NA. Genetics of Multiple Sclerosis: An Overview and New Directions. Cold Spring Harb Perspect Med. 2018;8(7):a028951. doi: 10.1101/cshperspect.a028951. PMID: 29440325; PMCID: PMC6027932. Go to original source... Go to PubMed...
  21. Rajabli F, Feliciano BE, Celis K, et al. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 2018;14(12):e1007791. doi:10.1371/journal.pgen.1007791. PMID: 30517106; PMCID: PMC6281216. Go to original source... Go to PubMed...
  22. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet. 2001;17(9):502-10. doi: 10.1016/s0168-9525(01)02410-6. PMID: 11525833. Go to original source... Go to PubMed...
  23. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996 Sep 13;273(5281):1516-7. doi: 10.1126/science.273.5281.1516. PMID: 8801636. Go to original source... Go to PubMed...
  24. Sawcer S, Ban M, Maranian M, et al.; International Multiple Sclerosis Genetics Consortium. A high­‑density screen for linkage in multiple sclerosis. Am J Hum Genet. 2005;77(3):454-67. doi: 10.1086/444547. Epub 2005 Jul 29. PMID: 16080120; PMCID: PMC1226210. Go to original source... Go to PubMed...
  25. Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014 Jul;13(7):700-9. doi: 10.1016/S1474-4422(14)70041-9. Epub 2014 May 19. PMID: 24852507. Go to original source... Go to PubMed...
  26. Shams H, Shao X, Santaniello A, et al.; University of California San Francisco MS­‑EPIC Team; Schaefer CA, McCauley JL, Cree BAC, Didonna A, Baranzini SE, Patsopoulos NA, Hauser SL, Barcellos LF, Henry RG, Oksenberg JR. Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans. Brain. 2023;146(2):645-656. doi: 10.1093/brain/awac092. PMID: 35253861; PMCID: PMC10169285. Go to original source... Go to PubMed...
  27. Soskic B, Cano­‑Gamez E, Smyth DJ, et al. Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation. Nat Genet. 2022;54(6):817-826. doi: 10.1038/s41588-022-01066-3. Epub 2022 May 26. PMID: 35618845; PMCID: PMC9197762. Go to original source... Go to PubMed...
  28. Steri M, Orrù V, Idda ML, et al.Overexpression of the Cytokine BAFF and Autoimmunity Risk. N Engl J Med. 2017;376(17):1615-1626. doi: 10.1056/NEJMoa1610528. PMID: 28445677; PMCID: PMC5605835. Go to original source... Go to PubMed...
  29. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. PMID: 29275977. Go to original source... Go to PubMed...
  30. Vandebergh M, Dubois B, Goris A. Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1165. doi: 10.1212/NXI.0000000000001165. PMID: 35393342; PMCID: PMC8990978. Go to original source... Go to PubMed...
  31. Vandebergh M, Goris A. Smoking and multiple sclerosis risk: a Mendelian randomization study. J Neurol. 2020;267(10):3083-3091. doi: 10.1007/s00415-020-09980-4. Epub 2020 Jun 11. PMID: 32529581; PMCID: PMC7501136. Go to original source... Go to PubMed...
  32. Visscher PM, Yengo L, Cox NJ, Wray NR. Discovery and implications of polygenicity of common diseases. Science. 2021;373(6562):1468-1473. doi: 10.1126/science.abi8206. Epub 2021 Sep 23. PMID: 34554790; PMCID: PMC9945947. Go to original source... Go to PubMed...
  33. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-1821. doi: 10.1177/1352458520970841. Epub 2020 Nov 11. PMID: 33174475; PMCID: PMC7720355. Go to original source... Go to PubMed...
  34. Westerlind H, Ramanujam R, Uvehag D, et al. Modest familial risks for multiple sclerosis: a registry­‑based study of the population of Sweden. Brain. 2014;137(Pt 3):770-8. doi: 10.1093/brain/awt356. Epub 2014 Jan 17. PMID: 24441172; PMCID: PMC3927700. Go to original source... Go to PubMed...
  35. Yuan S, Xiong Y, Larsson SC. An atlas on risk factors for multiple sclerosis: a Mendelian randomization study. J Neurol. 2021;268(1):114-124. doi: 10.1007/s00415-020-10119-8. Epub 2020 Jul 29. PMID: 32728946; PMCID: PMC7815542. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.